Stay updated on PK and QTc Interaction in Sitravatinib Clinical Trial
Sign up to get notified when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.

Latest updates to the PK and QTc Interaction in Sitravatinib Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Location sections for Indiana, Texas, Virginia, and Washington and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the prior Indiana, Texas, Virginia, and Washington location listings.SummaryDifference0.5%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; this appears to be a minor backend update with no changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedFooter shows Revision: v3.3.1 and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check43 days agoChange DetectedThe government funding notice about data currency and NIH operations was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check58 days agoChange DetectedScreenshots show minor formatting and layout differences without changes to the study design, inclusion criteria, primary outcomes, or location details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedUpdate includes a critical operating status notice and an explicit software version bump to v3.2.0, indicating updated information and improved operations.SummaryDifference5%

Stay in the know with updates to PK and QTc Interaction in Sitravatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.